- Drug R&D
- Animal / Plant
In the current post-human-genome-project era, next-generation sequencing (NGS) technologies promise to accelerate human genetic studies tremendously. The International HapMap and 1,000 Genomes Projects have identified numerous valuable genetic variants—many of which have been annotated extensively at single-base resolution. This information in turn has fueled research in many areas including:
- Human disease research & association studies
- Advances in Cancer research
- Population genetics & comparative genomics
- Pharmacogenomic studies & Personalized medicine
However, much discovery remains: we seek to identify important rare variants, understand disease inheritance, and realize the goal of therapies based on personal genomics. NGS technologies make these goals possible and promise a way to exploit the complexity of the human genome. With NGS technologies fueling the diverse palette of analytical and bioinformatics technologies available today, we can now take a systems biology approach to human disease research that includes genetic, epigenetic, and pathway perspectives.
At BGI, we leverage the full spectrum sequencing and multi-omic technologies as well as bioinformatics expertise to help accelerate your research so you can find answers to the important research questions that impact human health. To learn more, download the technical brochure Human Disease Research in the Multi-Omics Era and our Publication highlights.